V-domain immunoglobulin suppressor of T cell activation (VISTA) is a novel inhibitory immune checkpoints (ICs) that is expressed on myeloid cells, lymphoid cells, and tumoral cells; therefore, VISTA can substantially regulate innate and
adaptive anti-tumoral immune responses. VISTA is a transmembrane protein that plays a crucial role in the regulation of antitumor immunity. Therapeutic intervention that inhibits the VISTA pathway constitutes a new approach in the treatment of cancer.
HMBD-002 是一种靶向 VISTA 和 VSIG3 的非 Fc 依赖性、非耗竭型 IgG4 亚型抗体,广泛用于结肠癌、三阴性乳腺癌、非小细胞肺癌等多种实体瘤的相关研究,其通过阻断 VISTA 与 VSIG3 及 LRIG1 的相互作用,在不耗竭 VISTA 阳性细胞的前提下解除免疫抑制、激活 CD8+ T 细胞毒性程序并驱动 I 型干扰素信号通路,同时将肿瘤相关巨噬细胞重编程为 M1 表型并减少抑制性髓样细胞的肿瘤浸润,从而显著抑制肿瘤生长并改善生存期,且在啮齿类和非人灵长类动物模型中耐受性良好;HMBD-002 的同型对照是 Human IgG4 (S228P) kappa, Isotype Control (MS-E39019)。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号